Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2003 1
2006 1
2009 1
2010 2
2015 2
2016 3
2017 4
2018 2
2019 4
2020 4
2021 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Increased risk of giant cell tumor of bone"
Page 1
Paget's Disease of Bone.
Gennari L, Rendina D, Falchetti A, Merlotti D. Gennari L, et al. Calcif Tissue Int. 2019 May;104(5):483-500. doi: 10.1007/s00223-019-00522-3. Epub 2019 Jan 23. Calcif Tissue Int. 2019. PMID: 30671590 Review.
Paget's disease of bone (PDB) is a chronic and focal bone disorder, characterized by increased osteoclast-mediated bone resorption and a subsequent compensatory increase in bone formation, resulting in a disorganized mosaic of woven and l …
Paget's disease of bone (PDB) is a chronic and focal bone disorder, characterized by increased osteoclast-mediated b …
Depression and anxiety in recurrent giant cell tumor of bone.
Jidveian Popescu M, Stoicea MC, Marinescu I, Cismaşiu RS, Stovicek PO, Tudose C, Ciobanu AM. Jidveian Popescu M, et al. Rom J Morphol Embryol. 2020 Oct-Dec;61(4):1057-1065. doi: 10.47162/RJME.61.4.08. Rom J Morphol Embryol. 2020. PMID: 34171055 Free PMC article.
Giant cell tumor of bone (GCTB) is a benign neoplasia more frequently encountered in young females. ...Cytokine mechanisms, especially through increased tumor necrosis factor alpha (TNFalpha) and interleukin-6 (IL-6), as well as th …
Giant cell tumor of bone (GCTB) is a benign neoplasia more frequently encountered in young females. ...Cy …
Giant Cell Tumor (tumor gigantocellularis, osteoclastoma) - epidemiology, diagnosis, treatment.
Karpik M. Karpik M. Ortop Traumatol Rehabil. 2010 May-Jun;12(3):207-15. Ortop Traumatol Rehabil. 2010. PMID: 20675862 Review. English, Polish.
The author presents the epidemiology, classification, clinical features and strategies of treatment of Giant Cell Tumor. Giant Cell Tumor of Bone accounts for 4-8% of primary bone tumors. ...The recurrence rate is hig …
The author presents the epidemiology, classification, clinical features and strategies of treatment of Giant Cell Tumor …
Association between preoperative denosumab and the risk of local recurrence in patients with giant cell tumor of bone: A meta-analysis and systematic review.
Sun Z, Wu Z, Zhang L, Jia Q, Zhou Z, Xiao J. Sun Z, et al. J Cancer Res Ther. 2023 Feb;19(1):25-33. doi: 10.4103/jcrt.jcrt_1171_22. J Cancer Res Ther. 2023. PMID: 37006039 Free article.
OBJECTIVES: This meta-analysis aimed at determining the association between preoperative denosumab and the risk of local recurrence in patients with giant cell tumors of the bone. ...CONCLUSION: Denosumab before curettage may increase the …
OBJECTIVES: This meta-analysis aimed at determining the association between preoperative denosumab and the risk of local recur …
Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence?
Scoccianti G, Totti F, Scorianz M, Baldi G, Roselli G, Beltrami G, Franchi A, Capanna R, Campanacci DA. Scoccianti G, et al. Clin Orthop Relat Res. 2018 Sep;476(9):1783-1790. doi: 10.1007/s11999.0000000000000104. Clin Orthop Relat Res. 2018. PMID: 30778015 Free PMC article.
BACKGROUND: Denosumab is a monoclonal RANKL antibody, which was originally introduced for the treatment of osteoporosis and bone metastases from solid tumors, but more recently has been used for treatment of giant cell tumor of bone (GCTB …
BACKGROUND: Denosumab is a monoclonal RANKL antibody, which was originally introduced for the treatment of osteoporosis and bone meta …
Giant cell tumor of bone with secondary aneurysmal bone cyst does not have a higher risk of local recurrence.
Tsukamoto S, Aiba H, Righi A, Nitta Y, Traversari M, Mavrogenis AF, Honoki K, Tanaka Y, Donati DM, Errani C. Tsukamoto S, et al. J Surg Oncol. 2023 Aug;128(2):350-358. doi: 10.1002/jso.27283. Epub 2023 Apr 13. J Surg Oncol. 2023. PMID: 37053028
BACKGROUND: Fluid-fluid levels (FFLs) is found in 10%-16% of giant cell tumor of bone (GCTB), and the presence of FFLs raises the suspicion of GCTB with secondary aneurysmal bone cyst (ABC), which can lead to increased intraoperati …
BACKGROUND: Fluid-fluid levels (FFLs) is found in 10%-16% of giant cell tumor of bone (GCTB), and the pre …
Risk factors for pulmonary metastases from giant cell tumor of bone.
Chan CM, Adler Z, Reith JD, Gibbs CP Jr. Chan CM, et al. J Bone Joint Surg Am. 2015 Mar 4;97(5):420-8. doi: 10.2106/JBJS.N.00678. J Bone Joint Surg Am. 2015. PMID: 25740033
BACKGROUND: Giant cell tumor (GCT) of bone is a rare, benign, aggressive bone tumor with an unusual capacity to metastasize to the lung. ...CONCLUSIONS: There is an increased risk of pulmonary metastasis of GCT of …
BACKGROUND: Giant cell tumor (GCT) of bone is a rare, benign, aggressive bone tumor with an unusua …
Thallium-201 Uptake of Giant Cell Tumor: One Step Toward the Differential Diagnosis to Atypically Presenting Osteosarcoma.
Keller S, Inai R, Sato S, Tada A, Adam G, Yamamura J, Kanazawa S. Keller S, et al. AJR Am J Roentgenol. 2017 Jan;208(1):171-179. doi: 10.2214/AJR.16.16359. Epub 2016 Oct 11. AJR Am J Roentgenol. 2017. PMID: 27726429
OBJECTIVE: The radiologic differential diagnosis of giant cell tumors (GCTs) is challenging because there is a risk of misdiagnosis of GCTs as malignant lesions such as atypically presenting osteosarcomas (OSs). ...The delayed phase TBC was increase …
OBJECTIVE: The radiologic differential diagnosis of giant cell tumors (GCTs) is challenging because there is a risk …
Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.
Agarwal MG, Gundavda MK, Gupta R, Reddy R. Agarwal MG, et al. Clin Orthop Relat Res. 2018 Sep;476(9):1773-1782. doi: 10.1007/s11999.0000000000000243. Clin Orthop Relat Res. 2018. PMID: 30794215 Free PMC article.
BACKGROUND: Although giant cell tumors (GCTs) are benign, their aggressiveness and tendency to recur locally challenge the orthopaedic surgeon's ability to perform joint-preserving intralesional surgery with an acceptably low risk of local recurrence. …
BACKGROUND: Although giant cell tumors (GCTs) are benign, their aggressiveness and tendency to recur locally challenge the ort …
Risk factors for early dislocation of the hip after periacetabular tumour resection and endoprosthetic reconstruction of the hemipelvis.
Wang H, Tang X, Ji T, Yan T, Yang R, Guo W. Wang H, et al. Bone Joint J. 2021 Feb;103-B(2):382-390. doi: 10.1302/0301-620X.103B2.BJJ-2020-0928.R1. Bone Joint J. 2021. PMID: 33517736
AIMS: There is an increased risk of dislocation of the hip after the resection of a periacetabular tumour and endoprosthetic reconstruction of the defect in the hemipelvis. ...Cite this article: Bone Joint J 2021;103-B(2):382-390....
AIMS: There is an increased risk of dislocation of the hip after the resection of a periacetabular tumour and endoprost …
28 results